BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$981M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$944M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$873M |
| 5 |
Microsoft
MSFT
|
+$816M |
Top Sells
| 1 |
Home Depot
HD
|
+$243M |
| 2 |
Fiserv
FI
|
+$152M |
| 3 |
American Tower
AMT
|
+$144M |
| 4 |
Tesla
TSLA
|
+$138M |
| 5 |
Uber
UBER
|
+$112M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Financials | 12.31% |
| 3 | Consumer Discretionary | 8.67% |
| 4 | Healthcare | 6.81% |
| 5 | Communication Services | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
BioSig Technologies, Inc. Common Stock
BSGM
$137M
| $13.6K | ﹤0.01% |
315
-140
| -31% | -$6.03K |
|
3102
Minerva Neurosciences
NERV
$15.2M
| $13.4K | ﹤0.01% |
575
-339
| -37% | -$7.91K |
|
3103
B2Gold
BTG
$5.6B
| $13.3K | ﹤0.01% |
3,083
+1,516
| +97% | +$6.53K |
|
|
ABTC
3104
American Bitcoin Corp. Class A Common Stock
ABTC
$771M
| $13.3K | ﹤0.01% |
1
-1
| -50% | -$13.3K |
|
3105
Angi Inc
ANGI
$819M
| $13.3K | ﹤0.01% |
102
+11
| +12% | +$1.43K |
|
3106
VolitionRX
VNRX
$65.7M
| $13.3K | ﹤0.01% |
3,507
-949
| -21% | -$3.59K |
|
3107
Aquestive Therapeutics
AQST
$606M
| $13K | ﹤0.01% |
2,495
-868
| -26% | -$4.51K |
|
3108
Viper Energy
VNOM
$6.32B
| $12.7K | ﹤0.01% |
874
+496
| +131% | +$7.22K |
|
3109
Marker Therapeutics
MRKR
$11M
| $12.4K | ﹤0.01% |
554
+44
| +9% | +$986 |
|
|
SCTL
3110
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $12.3K | ﹤0.01% |
4,396
+497
| +13% | +$1.39K |
|
3111
Rockwell Medical
RMTI
$62M
| $12.1K | ﹤0.01% |
946
-348
| -27% | -$4.44K |
|
3112
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $12K | ﹤0.01% |
92
| – | – |
|
3113
Adecoagro
AGRO
$803M
| $11.8K | ﹤0.01% |
1,500
| – | – |
|
|
LJPC
3114
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $11.8K | ﹤0.01% |
2,772
-1,147
| -29% | -$4.86K |
|
|
NH
3115
DELISTED
NantHealth, Inc
NH
| $11.6K | ﹤0.01% |
241
-128
| -35% | -$6.16K |
|
3116
Galectin Therapeutics
GALT
$299M
| $11.5K | ﹤0.01% |
5,285
-1,660
| -24% | -$3.6K |
|
|
CEMI
3117
DELISTED
Chembio diagnostics, Inc.
CEMI
| $11.3K | ﹤0.01% |
3,226
-888
| -22% | -$3.12K |
|
3118
Cibus
CBUS
$68.3M
| $11.3K | ﹤0.01% |
38
-21
| -36% | -$6.26K |
|
|
OFED
3119
DELISTED
Oconee Federal Financial Corp.
OFED
| $11.2K | ﹤0.01% |
429
+283
| +194% | +$7.38K |
|
3120
Zymeworks
ZYME
$1.15B
| $11.1K | ﹤0.01% |
352
+279
| +382% | +$8.81K |
|
3121
Eletrobras Common Shares
EBR
$18.8B
| $11.1K | ﹤0.01% |
1,820
-603
| -25% | -$3.68K |
|
|
ELOX
3122
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $11.1K | ﹤0.01% |
83
-45
| -35% | -$6.01K |
|
|
SA
3123
Seabridge Gold
SA
$1.83B
| $10.5K | ﹤0.01% |
648
-8
| -1% | -$129 |
|
3124
Copel
ELP
$6.69B
| $10.5K | ﹤0.01% |
2,078
+868
| +72% | +$4.37K |
|
|
XLRN
3125
DELISTED
Acceleron Pharma Inc.
XLRN
| $10.4K | ﹤0.01% |
77
-1,720
| -96% | -$233K |
|